EVENTIDE ASSET MANAGEMENT, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share (INZY)

Filing Manager
EVENTIDE ASSET MANAGEMENT, LLC
Reporting Manager
Eventide Asset Management, LLC
Security
Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share
Symbol
INZY
Shares outstanding
64.2M shares
Disclosed Ownership
2.22M shares
Ownership
3.46%
Form type
SCHEDULE 13G/A
Filing time
23 Apr 2025, 10:28:29 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Eventide Asset Management, LLC 3.46% 2.22M 2.22M 0 /s/ Peter J. Luiso Peter J. Luiso, General Counsel
Finny Kuruvilla, M.D., Ph. D. 3.46% 2.22M 0 2.22M /s/ Finny Kuruvilla, M.D., Ph. D. Finny Kuruvilla, M.D., Ph. D.
Robin C. John 3.46% 2.22M 0 2.22M /s/ Robin C. John Robin C. John